Emergent BioSolutions (EBS) Other Non-Current Liabilities (2010 - 2026)
Emergent BioSolutions' Other Liabilities came in at $30.1 million for Q3 2026, down 29.3% from $42.6 million a year earlier and down 15.0% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions' Other Liabilities was $53.9 million, up 37.9% from FY2024.
- Other Liabilities carries a five-year compound annual growth rate of -19.6% (FY2020 to FY2025).
- Going back by year, Other Liabilities was $39.1 million in FY2024 (+35.3%), $28.9 million in FY2023 (-30.4%), $41.5 million in FY2022 (-40.3%) and $69.5 million in FY2021 (-56.6%).
- The Q3 2026 figure represents the lowest quarterly Other Liabilities since Q2 2024.
- Year-over-year, Other Liabilities increased in six of the last eight quarters, with growth averaging 18.8%.
- The fastest year-over-year change in Other Liabilities over five years came in Q2 2025 (growth of 53.7%), and the weakest in Q1 2023 (a decline of 60.7%).
- Business Quant data shows EBS's Other Liabilities at $35.4 million (Q2 2026), $41.7 million (Q1 2026) and $53.9 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 30.10 Mn |
| Jun 30, 2026 | 35.40 Mn |
| Mar 31, 2026 | 41.70 Mn |
| Dec 31, 2025 | 53.90 Mn |
| Sep 30, 2025 | 42.60 Mn |
| Jun 30, 2025 | 39.50 Mn |
| Mar 31, 2025 | 35.40 Mn |
| Dec 31, 2024 | 39.10 Mn |
| Sep 30, 2024 | 35.80 Mn |
| Jun 30, 2024 | 25.70 Mn |
| Mar 31, 2024 | 28.00 Mn |
| Dec 31, 2023 | 28.90 Mn |
| Sep 30, 2023 | 31.30 Mn |
| Jun 30, 2023 | 23.40 Mn |
| Mar 31, 2023 | 24.10 Mn |
| Dec 31, 2022 | 41.50 Mn |
| Sep 30, 2022 | 52.30 Mn |
| Jun 30, 2022 | 58.50 Mn |
| Mar 31, 2022 | 61.30 Mn |
| Dec 31, 2021 | 69.50 Mn |
API Access
Emergent BioSolutions Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();